Fractional CO₂ Laser for Primary Cutaneous Amyloidosis | MicrobiomeTrials← Back to trialsNCT07815132
Fractional CO₂ Laser for Primary Cutaneous Amyloidosis
CompletedNAINTERVENTIONAL
Trial Details
Start: 2024-09-10Est. Completion: 2025-06-24
Enrollment target: 22 participants Locations- Tanta University Hospitals, Tanta, Egypt
Other microbiome trials you might be interested in
Alzheimer's Disease
This study will evaluate the efficacy and safety of trontinemab in participants with biomarker evidence of Alzheimer's D…
Irvine, United StatesEst. completion Sep 3, 2032
PGM3 DeficiencyEosinophilic and/or Atopic DermatitisOSMR DeficiencyPrimary Localized Cutaneous AmyloidosisHereditary Alpha-tryptasemia
Background:
\- Allergic inflammation is central to allergy-related diseases and disorders, such as asthma, food allergi…
Bethesda, United States
Hereditary Corneal DystrophyCorneal AbnormalityCorneal DystrophiesCorneal Dystrophies, Hereditary
The goal of this clinical trial is to evaluate the safety and efficacy of GEB-101 injection in subjects with TGFBI-relat…
Los Angeles, United StatesEst. completion Aug 2027